Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Contribution of the PALB2 c.2323C>T [p.Q775X] Founder mutation in well-defined breast and/or ovarian cancer families and unselected ovarian cancer cases of French Canadian descent
Authors
Keywords
<em class=EmphasisTypeItalic >PALB2</em>, p.Q775X, p.Q775*, Hereditary breast cancer, Breast cancer risk, Ovarian cancer, Founder mutations, French Canadians
Journal
BMC Medical Genetics
Volume 14, Issue 1, Pages -
Publisher
Springer Nature
Online
2013-01-10
DOI
10.1186/1471-2350-14-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Rare occurrence of PALB2 mutations in ovarian cancer patients from the Volga-Ural region
- (2012) D Prokofyeva et al. CLINICAL GENETICS
- Rare germline mutations inPALB2and breast cancer risk: A population-based study
- (2012) Marc Tischkowitz et al. HUMAN MUTATION
- The BRCA2 c.9004G>A (E2003K) variant is likely pathogenic and recurs in breast and/or ovarian cancer families of French Canadian descent
- (2011) Stephanie Cote et al. BREAST CANCER RESEARCH AND TREATMENT
- Contribution of Inherited Mutations in the BRCA2-Interacting Protein PALB2 to Familial Breast Cancer
- (2011) S. Casadei et al. CANCER RESEARCH
- Chromosome 3 Anomalies Investigated by Genome Wide SNP Analysis of Benign, Low Malignant Potential and Low Grade Ovarian Serous Tumours
- (2011) Ashley H. Birch et al. PLoS One
- Mutations in 12 genes for inherited ovarian, fallopian tube, and peritoneal carcinoma identified by massively parallel sequencing
- (2011) T. Walsh et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A novel germline PALB2 deletion in Polish breast and ovarian cancer patients
- (2010) Agnieszka Dansonka-Mieszkowska et al. BMC Medical Genetics
- PALB2/FANCN: Recombining Cancer and Fanconi Anemia
- (2010) M. Tischkowitz et al. CANCER RESEARCH
- Discovering moderate-risk breast cancer susceptibility genes
- (2010) Antoinette Hollestelle et al. CURRENT OPINION IN GENETICS & DEVELOPMENT
- Comprehensive BRCA1 and BRCA2 mutation analyses and review of French Canadian families with at least three cases of breast cancer
- (2010) Luca Cavallone et al. Familial Cancer
- Evaluation of the Contribution of the Three Breast Cancer Susceptibility Genes CHEK2, STK11, and PALB2 in Non-BRCA1/2 French Canadian Families with High Risk of Breast Cancer
- (2010) Frédéric Guénard et al. Genetic Testing and Molecular Biomarkers
- The contribution of founder mutations to early-onset breast cancer in French-Canadian women
- (2009) P Ghadirian et al. CLINICAL GENETICS
- A PALB2 germline mutation associated with hereditary breast cancer in Italy
- (2009) Laura Papi et al. Familial Cancer
- PALB2 sequence variants in young South African breast cancer patients
- (2009) Michelle Sluiter et al. Familial Cancer
- Analysis of the Gene Coding for the BRCA2-Interacting Protein PALB2 in Familial and Sporadic Pancreatic Cancer
- (2009) Marc D. Tischkowitz et al. GASTROENTEROLOGY
- Exomic Sequencing Identifies PALB2 as a Pancreatic Cancer Susceptibility Gene
- (2009) S. Jones et al. SCIENCE
- The prevalence of PALB2 germline mutations in BRCA1/BRCA2 negative Chinese women with early onset breast cancer or affected relatives
- (2008) A-Yong Cao et al. BREAST CANCER RESEARCH AND TREATMENT
- Analysis of FANCB and FANCN/PALB2 Fanconi Anemia genes in BRCA1/2-negative Spanish breast cancer families
- (2008) María J. García et al. BREAST CANCER RESEARCH AND TREATMENT
- Promoter Hypermethylation of the PALB2 Susceptibility Gene in Inherited and Sporadic Breast and Ovarian Cancer
- (2008) A. Potapova et al. CANCER RESEARCH
- Inherited Susceptibility to Common Cancers
- (2008) William D. Foulkes NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started